Gabi Witt

Opinion author

Gabi Witt is a partner in Hogan Lovells’ Corporate & Finance practice and is based in the firm’s Washington, D.C. office. She focuses on mergers and acquisitions, venture capital, and private equity transactions. Gabi has significant experience advising strategic companies and fund-based investors on U.S. and cross-border acquisitions and divestments, financings, joint ventures, and general corporate and commercial matters. She represents clients in a range of industries, with a particular focus on the life sciences sector.

Direction uncertainty with a landscape of confused tangled roads and highways and a group of traffic signs competing for influence as a symbol of the challenges of planning a strategy for success.

Opinion

FDA uncertainty adds risk to biopharma deals

While merger and acquisition activity has been robust of late, frequent changes in guidance and leadership at the regulator add risk to any transaction.

June 24, 2026

3 min read

Jessica Bisignano